Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Ankylosing Spondylitis Drug Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Ankylosing Spondylitis Drug Market Status and Forecast (2016-2027)
      • 1.3.2 Global Ankylosing Spondylitis Drug Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Ankylosing Spondylitis Drug Supply by Company

    • 2.1 Global Ankylosing Spondylitis Drug Sales Value by Company
    • 2.2 Ankylosing Spondylitis Drug Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Ankylosing Spondylitis Drug Market Status by Category

    • 3.1 Ankylosing Spondylitis Drug Category Introduction
      • 3.1.1 Cimzia
      • 3.1.2 Enbrel
      • 3.1.3 Humira
      • 3.1.4 Remicade
      • 3.1.5 Simponi
      • 3.1.6 Others
    • 3.2 Global Ankylosing Spondylitis Drug Market by Category
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Ankylosing Spondylitis Drug Market Status by End User/Segment

    • 4.1 Ankylosing Spondylitis Drug Segment by End User/Segment
      • 4.1.1 Hospitals
      • 4.1.2 Clinics
    • 4.2 Global Ankylosing Spondylitis Drug Market by End User/Segment
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Ankylosing Spondylitis Drug Market Status by Region

    • 5.1 Global Ankylosing Spondylitis Drug Market by Region
    • 5.2 North America Ankylosing Spondylitis Drug Market Status
    • 5.3 Europe Ankylosing Spondylitis Drug Market Status
    • 5.4 Asia Pacific Ankylosing Spondylitis Drug Market Status
    • 5.5 Central & South America Ankylosing Spondylitis Drug Market Status
    • 5.6 Middle East & Africa Ankylosing Spondylitis Drug Market Status

    6 North America Ankylosing Spondylitis Drug Market Status

    • 6.1 North America Ankylosing Spondylitis Drug Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Ankylosing Spondylitis Drug Market Status

    • 7.1 Europe Ankylosing Spondylitis Drug Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Ankylosing Spondylitis Drug Market Status

    • 8.1 Asia Pacific Ankylosing Spondylitis Drug Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Ankylosing Spondylitis Drug Market Status

    • 9.1 Central & South America Ankylosing Spondylitis Drug Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Ankylosing Spondylitis Drug Market Status

    • 10.1 Middle East & Africa Ankylosing Spondylitis Drug Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Ankylosing Spondylitis Drug Market Forecast by Category and by End User/Segment

    • 12.1 Global Ankylosing Spondylitis Drug Sales Value Forecast (2022-2027)
    • 12.2 Global Ankylosing Spondylitis Drug Forecast by Category
    • 12.3 Global Ankylosing Spondylitis Drug Forecast by End User/Segment

    13 Global Ankylosing Spondylitis Drug Market Forecast by Region/Country

    • 13.1 Global Ankylosing Spondylitis Drug Market Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Wyeth
      • 14.1.1 Company Information
      • 14.1.2 Ankylosing Spondylitis Drug Product Introduction
      • 14.1.3 Wyeth Ankylosing Spondylitis Drug Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Takeda
      • 14.2.1 Company Information
      • 14.2.2 Ankylosing Spondylitis Drug Product Introduction
      • 14.2.3 Takeda Ankylosing Spondylitis Drug Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Schering-Plough
      • 14.3.1 Company Information
      • 14.3.2 Ankylosing Spondylitis Drug Product Introduction
      • 14.3.3 Schering-Plough Ankylosing Spondylitis Drug Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Pfizer
      • 14.4.1 Company Information
      • 14.4.2 Ankylosing Spondylitis Drug Product Introduction
      • 14.4.3 Pfizer Ankylosing Spondylitis Drug Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Mitsubishi Tanabe
      • 14.5.1 Company Information
      • 14.5.2 Ankylosing Spondylitis Drug Product Introduction
      • 14.5.3 Mitsubishi Tanabe Ankylosing Spondylitis Drug Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Johnson & Johnson
      • 14.6.1 Company Information
      • 14.6.2 Ankylosing Spondylitis Drug Product Introduction
      • 14.6.3 Johnson & Johnson Ankylosing Spondylitis Drug Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Eisai
      • 14.7.1 Company Information
      • 14.7.2 Ankylosing Spondylitis Drug Product Introduction
      • 14.7.3 Eisai Ankylosing Spondylitis Drug Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Centocor
      • 14.8.1 Company Information
      • 14.8.2 Ankylosing Spondylitis Drug Product Introduction
      • 14.8.3 Centocor Ankylosing Spondylitis Drug Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Amgen
      • 14.9.1 Company Information
      • 14.9.2 Ankylosing Spondylitis Drug Product Introduction
      • 14.9.3 Amgen Ankylosing Spondylitis Drug Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Abbott
      • 14.10.1 Company Information
      • 14.10.2 Ankylosing Spondylitis Drug Product Introduction
      • 14.10.3 Abbott Ankylosing Spondylitis Drug Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.10.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Ankylosing Spondylitis Drug market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Ankylosing Spondylitis Drug market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Cimzia
      Enbrel
      Humira
      Remicade
      Simponi
      Others

      Segmented by End User/Segment
      Hospitals
      Clinics

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Wyeth
      Takeda
      Schering-Plough
      Pfizer
      Mitsubishi Tanabe
      Johnson & Johnson
      Eisai
      Centocor
      Amgen
      Abbott
      Buy now